| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |